Hematopoetic Stem Cell Transplantation: Clinical Trials

9 trials for Hematopoetic Stem Cell Transplantation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 not yet recruiting, 3 recruiting, 1 completed. 4 Not applicable, 1 Early Phase 1, 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Not yet recruiting 2, Completed 1, Recruiting 1
Early Phase 11Recruiting 1
Phase 11Not yet recruiting 1
Phase 21Recruiting 1
Phase 31Not yet recruiting 1

Follow Hematopoetic Stem Cell Transplantation: new trials by email Literature Review of Hematopoetic Stem Cell Transplantation trials Research Report on Hematopoetic Stem Cell Transplantation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lisaftoclax Plus Azacitidine Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients at High Risk of Relapse
Lisaftoclax Plus Azacitidine - Acute Myeloid Leukemia (AML), Maintenance Treatment
Phase 3Not yet recruitingInstitute of Hematology & Blood Diseases Hospital, China1912026-08-102026-07-07
Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma
Therapeutic Inducers of Natural Killer Killing (ThINKK) - Leukaemia (Acute Lymphoblastic), Leukaemia (Acute Myeloid)
Phase 1Not yet recruitingMichel Duval122026-05-012026-04-08
Animation-Based Education to Reduce Child and Parent Anxiety During Pediatric Stem Cell Transplantation (Cartoon-HSCT)
Animation-Based Educational Video, Control Group: Standard Verbal Education - Hematopoetic Stem Cell Transplantation
Not applicableNot yet recruitingHacettepe University342026-04-012026-04-07
G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation
G-CSF+IL-11, G-CSF Granulocyte-Colony Stimulating Factor - Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB), Hematopoetic Stem Cell Transplantation
Phase 2RecruitingFudan University2242026-01-222026-10-22
Critical Illness After Hematopoietic Cell Transplantation
Critical Illness, Ventilated Patients
Not yet recruitingPeking University People's Hospital40002026-01-012026-01-09
Virtual Reality Intervention for Symptom Management in Stem Cell Transplantation
Virtual Reality Intervention - Cancer and / or Hematological Malignancy, Hematopoetic Stem Cell Transplantation
Not applicableNot yet recruitingHalic University302025-09-102025-08-28
Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers
Dyadic Problem Solving Training, Supportive Care - Stem Cell Transplant, Hematopoetic Stem Cell Transplant
Not applicableRecruitingUniversity of Pittsburgh2082025-07-012026-04-01
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
Exercise, Isoproterenol, Placebo - Leukemia, Hematopoetic Stem Cell Transplantation
Early Phase 1RecruitingUniversity of Arizona2002018-01-242026-06-05
Physical Exercise Therapy in Pediatric Stem Cell Transplantation
Exercise, Mental Training - Hematopoetic Stem Cell Transplantation
Not applicableCompletedJohann Wolfgang Goethe University Hospital682011-01-012015-04-01

Narrower conditions

Leukemia (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Motor Activity (2)  ·  Anxiety Disorders (1)  ·  Critical Illness (1)  ·  Hematologic Neoplasms (1)  ·  Lymphoma (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Neuroblastoma (1)  ·  Paroxysmal nonkinesigenic dyskinesia (1)  ·  Personal Satisfaction (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Behavior (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia, Myeloid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Disease Attributes (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)

Interventions

Exercise (2)  ·  1-(di-(2-pyridyl)methylene)-5-salicylidenethiocarbonohydrazide (1)  ·  Azacitidine (1)  ·  Bisoprolol (1)  ·  Carvedilol (1)  ·  Control Groups (1)  ·  Isoproterenol (1)  ·  Lisaftoclax (1)  ·  Nadolol (1)  ·  Palliative Care (1)  ·  Roflumilast (1)  ·  Tablets (1)

Sponsors

Fudan University (1)  ·  Hacettepe University (1)  ·  Halic University (1)  ·  Institute of Hematology & Blood Diseases Hospital, China (1)  ·  Johann Wolfgang Goethe University Hospital (1)  ·  Michel Duval (1)  ·  Peking University People's Hospital (1)  ·  University of Arizona (1)  ·  University of Pittsburgh (1)

Countries

China (2)  ·  United States (2)  ·  Canada (1)  ·  Germany (1)  ·  Turkey (Türkiye) (1)

Top investigators

Jiexian Ma (1)  ·  Michel Duval, MD (1)  ·  Nebahat Bora Gunes, Assistant Professor (1)  ·  Sabine Herblot, PhD (1)

Results publications

PMID 31089282, PMID 36189306, PMID 36719647, PMID 37077913, PMID 38592213, PMID 40311885, PMID 40574863, PMID 40940923, PMID 41194247, PMID 41538301, PMID 41776652, PMID 42845554

NIH funding

R01CA268004 (1), R01CA277493 (1)